Assoc Prof Dr. Erdal Sag | Emerging Trends | Best Researcher Award

๐Ÿ“š Summary

Assoc Prof Dr. Erdal Sag is a distinguished pediatric rheumatologist with extensive training and research experience in the field. He completed his medical education and residency at Hacettepe University, where he later pursued a fellowship in Pediatric Rheumatology. His research focuses on juvenile idiopathic arthritis and autoinflammatory diseases, significantly contributing to the understanding of disease pathogenesis and treatment.

Education

  • MD from Hacettepe University
  • MSc in Pediatric Basic Sciences

๐Ÿ”ฌ Research Interests

  • Juvenile Idiopathic Arthritis (JIA): Investigating T cell exhaustion profiles and their impact on disease progression and prognosis.
  • Autoinflammatory Diseases: Exploring the pathogenesis and therapeutic responses in conditions like Familial Mediterranean Fever.
  • Muscle Biopsy in Pediatric Dermatomyositis: Analyzing histopathological patterns to better understand disease sub-phenotypes.
  • Macrophage Activation Syndrome: Studying advanced treatment strategies and disease mechanisms.
  • Systemic Juvenile Idiopathic Arthritis: Researching novel therapeutic approaches and disease management strategies.

๐Ÿ†Awards & Honorsย 

  • Best Oral Presentation (3rd Prize) at the 5th National Pediatric Rheumatology Congress
  • FOREUM Abstract Award in Basic-Translational Science at EULAR 2022
  • Travel Awards from prestigious congresses, including EULAR and PReS

๐ŸŒย Research Training

  • Post-doctoral research at Aarhus University, Denmark, and University College London, UK

 

Publications

Detection of genetic mutations underlying early-onset systemic lupus erythematosus

  • Authors: Sener, S., Sag, E., Han, X., Zhou, Q., Ozen, S.
  • Journal: Lupus
  • Year: 2024

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

  • Authors: Temizoz, B., Shibahara, T., Hioki, K., Coban, C., Ishii, K.J.
  • Journal: Frontiers in Immunology
  • Year: 2024

Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: The TURSIS study

  • Authors: Sozeri, B., Demir, F., Barut, K., Kasapcopur, O., Ozen, S.
  • Journal: Clinical and Experimental Rheumatology
  • Year: 2024

Chronic non-bacterial osteomyelitis and immune checkpoint molecules

  • Authors: Kaya Akca, U., Sag, E., Aydฤฑn, B., Bilginer, Y., Ozen, S.
  • Journal: Clinical Rheumatology
  • Year: 2024

The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study

  • Authors: Batu, E.D., Demirkan, F.G., Sag, E., Swart, J.F., Uziel, Y..
  • Journal: Seminars in Arthritis and Rheumatism
  • Year: 2023